LSL Pharma Group Inc. (TSXV:LSL)
Canada
· Delayed Price · Currency is CAD 0.375
0.00 (0.00%)
At close: Dec 5, 2025
LSL Pharma Group Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | - | 3.32 | -8.47 | -8.06 | -1.78 | 0.61 | Upgrade
|
| Depreciation & Amortization | - | 1.51 | 1.13 | 1.05 | 0.97 | 0.91 | Upgrade
|
| Stock-Based Compensation | - | 0.42 | 2.12 | - | - | - | Upgrade
|
| Other Operating Activities | - | -2.91 | 2.9 | 0.88 | 1.71 | 1.65 | Upgrade
|
| Change in Accounts Receivable | - | -0.51 | -1.41 | 0.21 | 0.96 | -2.98 | Upgrade
|
| Change in Inventory | - | -1.77 | -1.15 | 1.21 | -2.04 | -1.96 | Upgrade
|
| Change in Accounts Payable | - | -1.3 | -1.97 | 1.62 | -0.38 | 1.53 | Upgrade
|
| Change in Unearned Revenue | - | - | -0.01 | 0.01 | -0.51 | -1.34 | Upgrade
|
| Change in Other Net Operating Assets | - | -0.41 | -0.2 | -0.08 | -0.03 | 0.42 | Upgrade
|
| Operating Cash Flow | - | -1.65 | -7.07 | -3.16 | -1.08 | -1.16 | Upgrade
|
| Capital Expenditures | - | -1.6 | -0.66 | -1 | -0.91 | -3.3 | Upgrade
|
| Cash Acquisitions | - | -3.26 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -1.08 | -0.36 | - | - | - | Upgrade
|
| Other Investing Activities | - | -1.52 | - | - | -0.12 | -0.99 | Upgrade
|
| Investing Cash Flow | - | -7.46 | -1.02 | -1 | -1.04 | -4.29 | Upgrade
|
| Short-Term Debt Issued | - | 0.4 | 0.2 | 3 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 8.76 | 4.05 | 0.96 | 5.32 | - | Upgrade
|
| Total Debt Issued | - | 9.15 | 4.24 | 3.96 | 5.32 | 2.1 | Upgrade
|
| Long-Term Debt Repaid | - | -5.92 | -3.84 | -1.83 | -4.98 | - | Upgrade
|
| Total Debt Repaid | - | -5.92 | -3.84 | -1.83 | -4.98 | -0.63 | Upgrade
|
| Net Debt Issued (Repaid) | - | 3.23 | 0.4 | 2.13 | 0.34 | 1.47 | Upgrade
|
| Issuance of Common Stock | - | 8.23 | 9.46 | 2.37 | 2.65 | 10.94 | Upgrade
|
| Other Financing Activities | - | -2.07 | -1.77 | -1.07 | -2.05 | -1.1 | Upgrade
|
| Financing Cash Flow | - | 9.4 | 8.1 | 3.42 | 0.94 | 11.31 | Upgrade
|
| Net Cash Flow | - | 0.29 | 0.01 | -0.74 | -1.18 | 5.85 | Upgrade
|
| Free Cash Flow | - | -3.25 | -7.73 | -4.16 | -2 | -4.47 | Upgrade
|
| Free Cash Flow Margin | - | -18.31% | -77.04% | -50.66% | -22.80% | -44.47% | Upgrade
|
| Free Cash Flow Per Share | - | -0.03 | -0.10 | -0.06 | -0.03 | -0.08 | Upgrade
|
| Cash Interest Paid | - | 1.22 | 1.04 | 0.88 | 1.26 | 0.94 | Upgrade
|
| Levered Free Cash Flow | - | -10.35 | -5.26 | -1.88 | -3.7 | - | Upgrade
|
| Unlevered Free Cash Flow | - | -9.16 | -4.16 | -1.02 | -2.63 | - | Upgrade
|
| Change in Working Capital | - | -3.99 | -4.74 | 2.97 | -1.99 | -4.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.